PTEO News Alert Proteo Inc (PTEO) 0.0800 02/15/2015 09:29:23

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proteo Inc (PTEO) 0.0800 $PTEO

Ischemia Reperfusion Injury - Pipeline Review, H1 2014
M2 - Mon Dec 15, 3:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/6pp4ft/ischemia) has announced the addition of the "Ischemia Reperfusion Injury - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Ischemia Reperfusion Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemia Reperfusion Injury and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Ischemia Reperfusion Injury - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Ischemia Reperfusion Injury pipeline depth and focus of Indication therapeutics - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Pharming Group N.V. - BioLineRx, Ltd. - Silence Therapeutics plc - Proteo, Inc. - Scynexis, Inc. - Prolong Pharmaceuticals - Trophos SA - Curatis Pharma GmbH - Alligator Bioscience AB - Opsona Therapeutics Ltd. - PledPharma AB - Zealand Pharma A/S - Omeros Corporation - Bolder Biotechnology, Inc. - Adienne S.r.l. - Genextra S.p.a. - KAEL-GemVax Co., Ltd. - Ischemix - APT Therapeutics, Inc. - Peptinnovate Limited For more information visit http://www.researchandmarkets.com/research/6pp4ft/ischemia
OMER: 20.63 (+0.13)

Proteo Biotech AG Expands Management Board
Business Wire - Fri Dec 05, 4:00AM CST
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the company strengthens its Management Board. The Supervisory Board of Proteo Biotech AG has appointed Dr. Juergen Paal as a new member of the company's Management Board, effective from Dec 1st, 2014. In this leadership role as Proteo Biotech AG's new Chief Operating Officer, he will be responsible for Proteo's clinical development program, product launch preparation, business development and partnering initiatives.

Proteo, Inc. / Proteo Biotech AG: Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery Completed
Business Wire - Fri Nov 21, 5:30AM CST
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the NHS Lothian's Edinburgh Heart Centre has completed final analysis of data from the investigator initiated Phase II clinical trial (EMPIRE study) with Proteo's drug candidate Elafin for prevention of myocardial injury after coronary artery bypass surgery (CABG). The EMPIRE study was designed as a randomized, double-blinded and placebo-controlled study on 87 patients to investigate the therapeutic potential of a single preoperative Elafin dose on postoperative myocardial injury. This was measured by troponin I plasma concentration which is released by damaged heart muscle cells and its plasma concentration correlates with overall damage of the heart muscle. It was assumed that this treatment would lower the troponin I release over 48 hours. Publication of the EMPIRE study results is planned in a peer reviewed journal.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Later's NYC Summit Reinvents Social Commerce Game Plan

Updated Category News Views 19

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 46

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout

Updated Category News Views 25

CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...

Continue Reading
Parallels Desktop: Top Dog for Windows on Mac

Updated Category News Views 57

A Simpler Way to Bridge the Mac and Windows World Seems like Parallels Desktop is once again flexing its muscles for Mac users in 2026. Expert Consumers out of New York just gave them the thumbs-up as the go-to pick for folks wanting to hitch their Mac wagon to Windows 11. And why not? Parallels lets you take a stroll through Windows land without cutting your Mac ties. A...

Continue Reading
Cosmetics Market Heads for $497.2B; AI Ushers New Era

Updated Category News Views 58

Eyes on the $497.2 Billion Cosmetics Prize There's a new game in town, and it’s painted with pastels and scented with the allure of growth. That’s right—cosmetics, my friend. We're talking a market that’s tipped to hit the $497.2 billion mark by 2031. That’s from a cool $348 billion in 2026, shooting up at a respectable 7.4% CAGR. Now, the usual culprits drive...

Continue Reading
Kargo's Tech Boosts Profit on Seafood Supply Chain

Updated Category News Views 100

Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...

Continue Reading
Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

Updated Category News Views 37

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Continue Reading
Golden State Dermatology Expands with Sparks Clinic Launch

Updated Category News Views 90

Northern Nevada's New Name in Dermatology Take a stroll down Ion Drive in Sparks, and you'll find a fresh face in town—and we're not talking about a new coffee shop. Nope, it's something with a lot more skin in the game. Golden State Dermatology (GSD) is setting up shop at 5070 Ion Drive, Suite 201, and the doors are wide open for locals seeking dermatological care. A...

Continue Reading
Common ADHD Accommodations Fail to Boost Performance

Updated Category News Views 14

Rethink ADHD Accommodations When it comes to ADHD, everyone ties the classic school accommodations to success. You give kids extra time, a quieter spot, and regular breaks, and you figure that's the magic formula, right? Well, hold onto your hats, because a fresh study out of Florida International University is flipping that script. Turns out, all those accommodations we...

Continue Reading
Greenland Energy's Bold Move: A Stake in East Greenland

Updated Category News Views 184

A Familiar Energy Terrain Shifts When Greenland Energy Company (NASDAQ:GLND) threw down the gauntlet by announcing their maneuver to scoop up 80 Mile plc, it wasn't just another day in the boardroom. It's a classic case of one strong entity eyeing consolidation to drill deeper, not just in the wells, but into the market psyche. The proposed all-share acquisition paves the...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Online Casinos in Canada by 2025

Updated Category News Views 182

The Evolving Landscape of Online Casinos in Canada The online casino scene in Canada is undergoing a dynamic transformation. As we look toward 2025, innovations are shaping the way players experience gaming, focusing on convenience, security, and player engagement. Recent studies highlight a growing expectation for casinos to not only offer diverse games but also excel in...

Continue Reading
Marex Group plc Investors Urged to Join Securities Fraud Class Action

Updated Category News Views 204

Investors Watch: The Marex Group plc Securities Fraud Class Action Investors, there's a significant opportunity unfolding regarding Marex Group plc (NASDAQ: MRX). If you purchased securities of Marex Group between specific dates, you might be eligible for compensation. This class action aims to address the securities fraud tied to the company's activities during that...

Continue Reading
Bitcoin's Bright Future: Crypto Regulation Talks Heat Up

Updated Category News Views 215

At the World Liberty Forum in Mar-a-Lago, Brian Armstrong, CEO of Coinbase (NASDAQ:COIN), joined Senator Bernie Moreno (R-Ohio) to dig into the evolving landscape of U.S. crypto regulation, stablecoins, and Bitcoin's long-term outlook. "Bitcoin Is Just Getting Started" Moreno confidently declared that Bitcoin (CRYPTO: BTC) is just warming up, stating he’d rather plunk...

Continue Reading
Innovative Digital Strategies for Naloxone Use and Overdose Awareness

Updated Category News Views 112

Transforming Overdose Prevention with NALCAM In a significant step toward enhancing community health, The Wright Center for Community Health has embarked on an innovative partnership with Contingency Management Innovations. Together, they are piloting an initiative focused on NALCAM, an exciting digital platform aimed at encouraging individuals to carry and effectively...

Continue Reading
Nigerian Physician Advocates Push for J-1 Visa Reforms

Updated Category News Views 301

Nigerian Physician Advocates Rally for J-1 Visa Fix The Nigerian Physician Advocacy Group (NPAG) is spearheading an urgent two-day Advocacy & Lobby Day. This important event will take place on Capitol Hill, focusing on the critical role that Nigerian American physicians play in alleviating healthcare disparities across the nation. NPAG will advocate for significant...

Continue Reading